A cloud robotics architecture for an emergency management and monitoring service in a smart cityenvironment

Cloud robotics is revolutionizing not only the robotics industry but also the ICT world, giving robots more storage and computing capacity, opening new scenarios that blend the physical to the digital world. In this vision new IT architectures are required to manage robots, retrieve data from them and create services to interact with users. In this paper a possible implementation of a cloud robotics architecture for the interaction between users and UAVs is described. Using the latter as monitoring agents, a service for fighting crime in urban environment is proposed, making one step forward towards the idea of smart cit

A Cloud Based Service for Management and Planning of Autonomous UAV Missions in Smart City Scenarios

Cloud Robotics is an emerging paradigm in which robots, seen as abstract agents, have the possibility to connect to a common network and share on a complex infrastructure the information and knowledge they gather about the physical world; or conversely consume the data collected by other agents or made available on accessible database and repositories. In this paper we propose an implementation of an emergency-management service exploiting the possibilities offered by cloud robotics in a smart city scenario. A high-level cloud-platform manages a number of unmanned aerial vehicles (quadrotor UAVs) with the goal of providing aerial support to citizens that require it via a dedicated mobile app. The UAV reaches the citizen while forwarding a realtime video streaming to a privileged user (police officer),connected to the same cloud platform, that is allowed to teleoperate it by remote

A cloud robotics architecture for an emergency management and monitoring service in a smart cityenvironment

Cloud robotics is revolutionizing not only the robotics industry but also the ICT world, giving robots more storage and computing capacity, opening new scenarios that blend the physical to the digital world. In this vision new IT architectures are required to manage robots, retrieve data from them and create services to interact with users. In this paper a possible implementation of a cloud robotics architecture for the interaction between users and UAVs is described. Using the latter as monitoring agents, a service for fighting crime in urban environment is proposed, making one step forward towards the idea of smart city

Comparing Usability of User Interfaces for Robotic Telepresence

In the last years, robotic telepresence solutions have received a significant attention from both the commercial and academic worlds, due to their ability to allow people to feel physically present at a remote place and move in it. Operating a mobile robot with some autonomous capabilities from distance can enable a wide range of mass-market applications, encompassing teleconferencing, virtual tourism, etc. In these scenarios, the possibility to interact with the robot in a natural way becomes of crucial importance. The aim of this paper is to investigate, through a comparative analysis, the usability of two major approaches used today for controlling telepresence robots, i.e., keyboard and point-and-click video navigation. A control system featuring the above interfaces plus a combination of the two has been developed, and applied to the operation of a prototype telepresence robot in an office scenario. The system additionally includes functionalities found in many research and industry solutions, like map-based localization and "augmented" navigation. Then, a user study has been performed to assess the usability of the various control modalities for the execution of some navigation tasks in the considered context. The study provided precious indications to be possibly exploited for guiding next developments in the field

Early and long-term outlook of percutaneous coronary intervention for bifurcation lesions in young patients

Coronary artery disease is most common in older patients, but may occur in younger subjects. The outlook of young patients after percutaneous coronary intervention (PCI) of challenging lesion subsets such as coronary bifurcations, is not established. We thus aimed to appraise the early and long-term results of PCI for bifurcations in young patients

Impact of environmental pollution and weather changes on the incidence of ST-elevation myocardial infarction

Background: Environmental pollution and weather changes unfavorably impact on cardiovascular disease. However, limited research has focused on ST-elevation myocardial infarction (STEMI), the most severe yet distinctive form of acute coronary syndrome. Methods and results: We appraised the impact of environmental and weather changes on the incidence of STEMI, analysing the bivariate and multivariable association between several environmental and atmospheric parameters and the daily incidence of STEMI in two large Italian urban areas. Specifically, we appraised: carbon monoxide (CO), nitrogen dioxide (NO2), nitric oxide (NOX), ozone, particulate matter smaller than 10 μm (PM10) and than 2.5 μm (PM2.5), temperature, atmospheric pressure, humidity and rainfall. A total of 4285 days at risk were appraised, with 3473 cases of STEMI. Specifically, no STEMI occurred in 1920 (44.8%) days, whereas one or more occurred in the remaining 2365 (55.2%) days. Multilevel modelling identified several pollution and weather predictors of STEMI. In particular, concentrations of CO (p=0.024), NOX (p=0.039), ozone (p=0.003), PM10 (p=0.033) and PM2.5 (p=0.042) predicted STEMI as early as three days before the event, as well as subsequently, and NO predicted STEMI one day before (p = 0.010), as well as on the same day. A similar predictive role was evident for temperature and atmospheric pressure (all p < 0.05). Conclusions: The risk of STEMI is strongly associated with pollution and weather features. While causation cannot yet be proven, environmental and weather changes could be exploited to predict STEMI risk in the following days

Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

Background and purpose: Prospectively collected data comparing the safety and effectiveness of individual non-vitamin K antagonists (NOACs) are lacking. Our objective was to directly compare the effectiveness and safety of NOACs in patients with newly diagnosed atrial fibrillation (AF). Methods: In GLORIA-AF, a large, prospective, global registry program, consecutive patients with newly diagnosed AF were followed for 3 years. The comparative analyses for (1) dabigatran vs rivaroxaban or apixaban and (2) rivaroxaban vs apixaban were performed on propensity score (PS)-matched patient sets. Proportional hazards regression was used to estimate hazard ratios (HRs) for outcomes of interest. Results: The GLORIA-AF Phase III registry enrolled 21,300 patients between January 2014 and December 2016. Of these, 3839 were prescribed dabigatran, 4015 rivaroxaban and 4505 apixaban, with median ages of 71.0, 71.0, and 73.0 years, respectively. In the PS-matched set, the adjusted HRs and 95% confidence intervals (CIs) for dabigatran vs rivaroxaban were, for stroke: 1.27 (0.79–2.03), major bleeding 0.59 (0.40–0.88), myocardial infarction 0.68 (0.40–1.16), and all-cause death 0.86 (0.67–1.10). For the comparison of dabigatran vs apixaban, in the PS-matched set, the adjusted HRs were, for stroke 1.16 (0.76–1.78), myocardial infarction 0.84 (0.48–1.46), major bleeding 0.98 (0.63–1.52) and all-cause death 1.01 (0.79–1.29). For the comparison of rivaroxaban vs apixaban, in the PS-matched set, the adjusted HRs were, for stroke 0.78 (0.52–1.19), myocardial infarction 0.96 (0.63–1.45), major bleeding 1.54 (1.14–2.08), and all-cause death 0.97 (0.80–1.19). Conclusions: Patients treated with dabigatran had a 41% lower risk of major bleeding compared with rivaroxaban, but similar risks of stroke, MI, and death. Relative to apixaban, patients treated with dabigatran had similar risks of stroke, major bleeding, MI, and death. Rivaroxaban relative to apixaban had increased risk for major bleeding, but similar risks for stroke, MI, and death. Registration: URL: https://www.clinicaltrials.gov. Unique identifiers: NCT01468701, NCT01671007. Date of registration: September 2013